Click for best price
Opioids Agonist Drugs Market Size, Share 2022
Market Analysis and Insights: Global Opioids Agonist Drugs Market
The global Opioids Agonist Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Opioids Agonist Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Opioids Agonist Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Opioids Agonist Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Opioids Agonist Drugs market.
Global Opioids Agonist Drugs Scope and Market Size
Opioids Agonist Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Opioids Agonist Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Opioids Agonist Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Segment by Application
Pain Management
Cough Treatment
Diarrhea Treatment
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Opioids Agonist Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Opioids Agonist Drugs, with price, sales, revenue, and global market share of Opioids Agonist Drugs from 2019 to 2022.
Chapter 3, the Opioids Agonist Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids Agonist Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Opioids Agonist Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Opioids Agonist Drugs.
Chapter 13, 14, and 15, to describe Opioids Agonist Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Opioids Agonist Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Opioids Agonist Drugs Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
105 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Opioids Agonist Drugs Product Introduction
1.2 Global Opioids Agonist Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Opioids Agonist Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Opioids Agonist Drugs Sales in Volume for the Year 2017-2028
1.3 United States Opioids Agonist Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Opioids Agonist Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Opioids Agonist Drugs Sales in Volume for the Year 2017-2028
1.4 Opioids Agonist Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Opioids Agonist Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Opioids Agonist Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Opioids Agonist Drugs Market Dynamics
1.5.1 Opioids Agonist Drugs Industry Trends
1.5.2 Opioids Agonist Drugs Market Drivers
1.5.3 Opioids Agonist Drugs Market Challenges
1.5.4 Opioids Agonist Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Opioids Agonist Drugs Market Segment by Type
2.1.1 Codeine
2.1.2 Fentanyl
2.1.3 Meperidine
2.1.4 Methadone
2.1.5 Morphine
2.1.6 Hydrocodone
2.2 Global Opioids Agonist Drugs Market Size by Type
2.2.1 Global Opioids Agonist Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Opioids Agonist Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Opioids Agonist Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Opioids Agonist Drugs Market Size by Type
2.3.1 United States Opioids Agonist Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Opioids Agonist Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Opioids Agonist Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Opioids Agonist Drugs Market Segment by Application
3.1.1 Pain Management
3.1.2 Cough Treatment
3.1.3 Diarrhea Treatment
3.2 Global Opioids Agonist Drugs Market Size by Application
3.2.1 Global Opioids Agonist Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Opioids Agonist Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Opioids Agonist Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Opioids Agonist Drugs Market Size by Application
3.3.1 United States Opioids Agonist Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Opioids Agonist Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Opioids Agonist Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Opioids Agonist Drugs Competitor Landscape by Company
4.1 Global Opioids Agonist Drugs Market Size by Company
4.1.1 Top Global Opioids Agonist Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Opioids Agonist Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Opioids Agonist Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Opioids Agonist Drugs Price by Manufacturer (2017-2022)
4.2 Global Opioids Agonist Drugs Concentration Ratio (CR)
4.2.1 Opioids Agonist Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Opioids Agonist Drugs in 2021
4.2.3 Global Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Opioids Agonist Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Opioids Agonist Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Opioids Agonist Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Opioids Agonist Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Opioids Agonist Drugs Market Size by Company
4.5.1 Top Opioids Agonist Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Opioids Agonist Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Opioids Agonist Drugs Sales by Players (2020, 2021 & 2022)
5 Global Opioids Agonist Drugs Market Size by Region
5.1 Global Opioids Agonist Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Opioids Agonist Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Opioids Agonist Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Opioids Agonist Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Opioids Agonist Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Opioids Agonist Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Opioids Agonist Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Opioids Agonist Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Opioids Agonist Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Opioids Agonist Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Opioids Agonist Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Opioids Agonist Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Opioids Agonist Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Opioids Agonist Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Opioids Agonist Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Opioids Agonist Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Opioids Agonist Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Purdue Pharma
7.1.1 Purdue Pharma Corporation Information
7.1.2 Purdue Pharma Description and Business Overview
7.1.3 Purdue Pharma Opioids Agonist Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Purdue Pharma Opioids Agonist Drugs Products Offered
7.1.5 Purdue Pharma Recent Development
7.2 Titan pharmaceuticals
7.2.1 Titan pharmaceuticals Corporation Information
7.2.2 Titan pharmaceuticals Description and Business Overview
7.2.3 Titan pharmaceuticals Opioids Agonist Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Titan pharmaceuticals Opioids Agonist Drugs Products Offered
7.2.5 Titan pharmaceuticals Recent Development
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporation Information
7.3.2 Boehringer Ingelheim Description and Business Overview
7.3.3 Boehringer Ingelheim Opioids Agonist Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Boehringer Ingelheim Opioids Agonist Drugs Products Offered
7.3.5 Boehringer Ingelheim Recent Development
7.4 Janssen Pharmaceuticals, Inc
7.4.1 Janssen Pharmaceuticals, Inc Corporation Information
7.4.2 Janssen Pharmaceuticals, Inc Description and Business Overview
7.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Products Offered
7.4.5 Janssen Pharmaceuticals, Inc Recent Development
7.5 Sanofi
7.5.1 Sanofi Corporation Information
7.5.2 Sanofi Description and Business Overview
7.5.3 Sanofi Opioids Agonist Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Sanofi Opioids Agonist Drugs Products Offered
7.5.5 Sanofi Recent Development
7.6 Sun Pharmaceuticals
7.6.1 Sun Pharmaceuticals Corporation Information
7.6.2 Sun Pharmaceuticals Description and Business Overview
7.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Sun Pharmaceuticals Opioids Agonist Drugs Products Offered
7.6.5 Sun Pharmaceuticals Recent Development
7.7 Mallinckrodt Pharmaceuticals
7.7.1 Mallinckrodt Pharmaceuticals Corporation Information
7.7.2 Mallinckrodt Pharmaceuticals Description and Business Overview
7.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Products Offered
7.7.5 Mallinckrodt Pharmaceuticals Recent Development
7.8 Egalet Corporation
7.8.1 Egalet Corporation Corporation Information
7.8.2 Egalet Corporation Description and Business Overview
7.8.3 Egalet Corporation Opioids Agonist Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Egalet Corporation Opioids Agonist Drugs Products Offered
7.8.5 Egalet Corporation Recent Development
7.9 Endo Pharmaceuticals Inc.
7.9.1 Endo Pharmaceuticals Inc. Corporation Information
7.9.2 Endo Pharmaceuticals Inc. Description and Business Overview
7.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Products Offered
7.9.5 Endo Pharmaceuticals Inc. Recent Development
7.10 Allergan, Plc
7.10.1 Allergan, Plc Corporation Information
7.10.2 Allergan, Plc Description and Business Overview
7.10.3 Allergan, Plc Opioids Agonist Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Allergan, Plc Opioids Agonist Drugs Products Offered
7.10.5 Allergan, Plc Recent Development
7.11 Pfizer Inc
7.11.1 Pfizer Inc Corporation Information
7.11.2 Pfizer Inc Description and Business Overview
7.11.3 Pfizer Inc Opioids Agonist Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Pfizer Inc Opioids Agonist Drugs Products Offered
7.11.5 Pfizer Inc Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Opioids Agonist Drugs Industry Chain Analysis
8.2 Opioids Agonist Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Opioids Agonist Drugs Distributors
8.3 Opioids Agonist Drugs Production Mode & Process
8.4 Opioids Agonist Drugs Sales and Marketing
8.4.1 Opioids Agonist Drugs Sales Channels
8.4.2 Opioids Agonist Drugs Distributors
8.5 Opioids Agonist Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Opioids Agonist Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Opioids Agonist Drugs Market Trends
Table 3. Opioids Agonist Drugs Market Drivers
Table 4. Opioids Agonist Drugs Market Challenges
Table 5. Opioids Agonist Drugs Market Restraints
Table 6. Global Opioids Agonist Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Opioids Agonist Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Opioids Agonist Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Opioids Agonist Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Opioids Agonist Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Opioids Agonist Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Opioids Agonist Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Opioids Agonist Drugs Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Opioids Agonist Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Opioids Agonist Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Opioids Agonist Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Opioids Agonist Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids Agonist Drugs as of 2021)
Table 18. Top Players of Opioids Agonist Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Opioids Agonist Drugs Product Type
Table 20. Date of International Manufacturers Enter into Opioids Agonist Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Opioids Agonist Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Opioids Agonist Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Opioids Agonist Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Opioids Agonist Drugs Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Opioids Agonist Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Opioids Agonist Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Opioids Agonist Drugs Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Opioids Agonist Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Opioids Agonist Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Opioids Agonist Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Opioids Agonist Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Opioids Agonist Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Opioids Agonist Drugs Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Opioids Agonist Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Opioids Agonist Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Opioids Agonist Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Opioids Agonist Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Opioids Agonist Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Opioids Agonist Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Opioids Agonist Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Purdue Pharma Corporation Information
Table 43. Purdue Pharma Description and Business Overview
Table 44. Purdue Pharma Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Purdue Pharma Opioids Agonist Drugs Product
Table 46. Purdue Pharma Recent Development
Table 47. Titan pharmaceuticals Corporation Information
Table 48. Titan pharmaceuticals Description and Business Overview
Table 49. Titan pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Titan pharmaceuticals Product
Table 51. Titan pharmaceuticals Recent Development
Table 52. Boehringer Ingelheim Corporation Information
Table 53. Boehringer Ingelheim Description and Business Overview
Table 54. Boehringer Ingelheim Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Boehringer Ingelheim Product
Table 56. Boehringer Ingelheim Recent Development
Table 57. Janssen Pharmaceuticals, Inc Corporation Information
Table 58. Janssen Pharmaceuticals, Inc Description and Business Overview
Table 59. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Janssen Pharmaceuticals, Inc Product
Table 61. Janssen Pharmaceuticals, Inc Recent Development
Table 62. Sanofi Corporation Information
Table 63. Sanofi Description and Business Overview
Table 64. Sanofi Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Sanofi Product
Table 66. Sanofi Recent Development
Table 67. Sun Pharmaceuticals Corporation Information
Table 68. Sun Pharmaceuticals Description and Business Overview
Table 69. Sun Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Sun Pharmaceuticals Product
Table 71. Sun Pharmaceuticals Recent Development
Table 72. Mallinckrodt Pharmaceuticals Corporation Information
Table 73. Mallinckrodt Pharmaceuticals Description and Business Overview
Table 74. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Mallinckrodt Pharmaceuticals Product
Table 76. Mallinckrodt Pharmaceuticals Recent Development
Table 77. Egalet Corporation Corporation Information
Table 78. Egalet Corporation Description and Business Overview
Table 79. Egalet Corporation Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Egalet Corporation Product
Table 81. Egalet Corporation Recent Development
Table 82. Endo Pharmaceuticals Inc. Corporation Information
Table 83. Endo Pharmaceuticals Inc. Description and Business Overview
Table 84. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Endo Pharmaceuticals Inc. Product
Table 86. Endo Pharmaceuticals Inc. Recent Development
Table 87. Allergan, Plc Corporation Information
Table 88. Allergan, Plc Description and Business Overview
Table 89. Allergan, Plc Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Allergan, Plc Product
Table 91. Allergan, Plc Recent Development
Table 92. Pfizer Inc Corporation Information
Table 93. Pfizer Inc Description and Business Overview
Table 94. Pfizer Inc Opioids Agonist Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Pfizer Inc Product
Table 96. Pfizer Inc Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Opioids Agonist Drugs Customers List
Table 100. Opioids Agonist Drugs Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Agonist Drugs Product Picture
Figure 2. Global Opioids Agonist Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Opioids Agonist Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Opioids Agonist Drugs Sales 2017-2028 (K Units)
Figure 5. United States Opioids Agonist Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Opioids Agonist Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Opioids Agonist Drugs Sales 2017-2028 (K Units)
Figure 8. United States Opioids Agonist Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Opioids Agonist Drugs Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Opioids Agonist Drugs Report Years Considered
Figure 11. Product Picture of Codeine
Figure 12. Product Picture of Fentanyl
Figure 13. Product Picture of Meperidine
Figure 14. Product Picture of Methadone
Figure 15. Product Picture of Morphine
Figure 16. Product Picture of Hydrocodone
Figure 17. Global Opioids Agonist Drugs Market Share by Type in 2022 & 2028
Figure 18. Global Opioids Agonist Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 19. Global Opioids Agonist Drugs Sales Market Share in Value by Type (2017-2028)
Figure 20. Global Opioids Agonist Drugs Sales by Type (2017-2028) & (K Units)
Figure 21. Global Opioids Agonist Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 22. Global Opioids Agonist Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 23. United States Opioids Agonist Drugs Market Share by Type in 2022 & 2028
Figure 24. United States Opioids Agonist Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 25. United States Opioids Agonist Drugs Sales Market Share in Value by Type (2017-2028)
Figure 26. United States Opioids Agonist Drugs Sales by Type (2017-2028) & (K Units)
Figure 27. United States Opioids Agonist Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 28. United States Opioids Agonist Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 29. Product Picture of Pain Management
Figure 30. Product Picture of Cough Treatment
Figure 31. Product Picture of Diarrhea Treatment
Figure 32. Global Opioids Agonist Drugs Market Share by Application in 2022 & 2028
Figure 33. Global Opioids Agonist Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 34. Global Opioids Agonist Drugs Sales Market Share in Value by Application (2017-2028)
Figure 35. Global Opioids Agonist Drugs Sales by Application (2017-2028) & (K Units)
Figure 36. Global Opioids Agonist Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 37. Global Opioids Agonist Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 38. United States Opioids Agonist Drugs Market Share by Application in 2022 & 2028
Figure 39. United States Opioids Agonist Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 40. United States Opioids Agonist Drugs Sales Market Share in Value by Application (2017-2028)
Figure 41. United States Opioids Agonist Drugs Sales by Application (2017-2028) & (K Units)
Figure 42. United States Opioids Agonist Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 43. United States Opioids Agonist Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 44. North America Opioids Agonist Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 45. North America Opioids Agonist Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. U.S. Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Canada Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Europe Opioids Agonist Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 49. Europe Opioids Agonist Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 50. Germany Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. France Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. U.K. Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Italy Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Russia Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Asia-Pacific Opioids Agonist Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 56. Asia-Pacific Opioids Agonist Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 57. China Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Japan Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. South Korea Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. India Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Australia Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Taiwan Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Indonesia Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Thailand Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Malaysia Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Philippines Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Latin America Opioids Agonist Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 68. Latin America Opioids Agonist Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Mexico Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Brazil Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Argentina Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Middle East & Africa Opioids Agonist Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 73. Middle East & Africa Opioids Agonist Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 74. Turkey Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Saudi Arabia Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. U.A.E Opioids Agonist Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. Opioids Agonist Drugs Value Chain
Figure 78. Opioids Agonist Drugs Production Process
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
